NZ568391A - Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens - Google Patents

Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens

Info

Publication number
NZ568391A
NZ568391A NZ568391A NZ56839103A NZ568391A NZ 568391 A NZ568391 A NZ 568391A NZ 568391 A NZ568391 A NZ 568391A NZ 56839103 A NZ56839103 A NZ 56839103A NZ 568391 A NZ568391 A NZ 568391A
Authority
NZ
New Zealand
Prior art keywords
bacillus subtilis
composition according
cells
exposure
fermented extracts
Prior art date
Application number
NZ568391A
Other languages
English (en)
Inventor
Huay Lin Angeline Seah
Alex Yeow-Lim Teo
Hai Meng Tan
Original Assignee
Kemin Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Ind Inc filed Critical Kemin Ind Inc
Publication of NZ568391A publication Critical patent/NZ568391A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ568391A 2002-11-27 2003-11-12 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens NZ568391A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/306,365 US7247299B2 (en) 2002-11-27 2002-11-27 Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens

Publications (1)

Publication Number Publication Date
NZ568391A true NZ568391A (en) 2009-04-30

Family

ID=32325671

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ568391A NZ568391A (en) 2002-11-27 2003-11-12 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens

Country Status (10)

Country Link
US (1) US7247299B2 (enExample)
EP (1) EP1576120B1 (enExample)
JP (1) JP4989851B2 (enExample)
AT (1) ATE440132T1 (enExample)
AU (1) AU2003291514B2 (enExample)
CA (1) CA2503130C (enExample)
DE (1) DE60328916D1 (enExample)
ES (1) ES2331993T3 (enExample)
NZ (1) NZ568391A (enExample)
WO (1) WO2004050832A2 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004104175A2 (en) * 2003-05-14 2004-12-02 University Of Georgia Research Foundation, Inc. Probiotic bacteria and methods
CA2566617C (en) 2004-05-14 2013-12-31 Agtech Products, Inc. Method and composition for reducing e.coli disease and enhancing performance using bacillus
US20080193577A1 (en) * 2005-11-04 2008-08-14 Ahc Co., Ltd. Antibacterial Substance Dm0507 and Utilization of the Same
US20080057047A1 (en) * 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
US7754469B2 (en) * 2005-11-30 2010-07-13 Agtech Products, Inc Microorganisms and methods for treating poultry
US8021654B2 (en) 2008-03-14 2011-09-20 Danisco A/S Methods of treating pigs with Bacillus strains
DK2274415T3 (da) * 2008-04-17 2016-04-04 Dupont Nutrition Biosci Aps Anvendelige bacillestammer til bekæmpelse af dyrelugt
US8540981B1 (en) 2008-07-07 2013-09-24 Dupont Nutrition Biosciences Aps Bacillus strains useful against calf pathogens and scours
BRPI0918033A8 (pt) * 2008-09-17 2017-10-03 Agraquest Inc Metodo para melhorar a saude de um animal nao inseto e nao humano, e, composicao para melhorar a condicao fisica de um animal nao inseto e nao humano
EP2367839A4 (en) * 2008-11-03 2012-07-04 Univ Tufts METHOD AND COMPOSITIONS FOR INHIBITING CLOSTRIDIUM DIFFICILE SPORTS NUTRITION AND GROWTH
EP2556835B1 (en) 2010-02-10 2015-08-05 Japan Eco-Science Co. Ltd. Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
WO2011116155A1 (en) * 2010-03-17 2011-09-22 Agraquest, Inc. Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
BR112013001107B1 (pt) 2010-07-16 2022-01-25 The Board Of Trustees Of The University Of Arkansas Métodos e composições incluindo bactéria formadora de esporos para aumento da saúde dos animais
MX339951B (es) * 2010-09-15 2016-06-20 Investig De Tecnologia Avanzada S A De C V Bacillus subtilis aislado de maiz.
US9107938B2 (en) 2010-09-30 2015-08-18 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
US9023345B2 (en) * 2011-03-01 2015-05-05 Novus International, Inc. Methods for improving gut health
EP2701535A2 (en) 2011-04-29 2014-03-05 Auburn University Bacillus bacteria for use in treating and preventing infection in aquatic animals
US8557234B1 (en) 2011-05-18 2013-10-15 Dupont Nutrition Biosciences Aps Methods of controlling pit foam
DK2748300T3 (en) 2011-08-24 2019-01-14 Dupont Nutrition Biosci Aps ENZYM-PRODUCING BACILLUS STUMS
US20150037307A1 (en) 2012-01-27 2015-02-05 Gfs Corporation Aus Pty Ltd. Poultry farm practices
WO2014022572A1 (en) 2012-08-01 2014-02-06 Pacific Vet Group-Usa, Inc. Probiotic for amelioration of coccidiosis vaccine reaction
RU2534356C2 (ru) * 2012-10-04 2014-11-27 Государственное научное учреждение Институт экспериментальной ветеринарии Сибири и Дальнего Востока Россельхозакадемии (ГНУ ИЭВСиДВ Россельхозакадемии) Способ контроля качества дезинфекции птицеводческих помещений
WO2014151837A1 (en) * 2013-03-15 2014-09-25 Bayer Cropscience Lp A bacillus subtilis strain for use in maintaining or improving the paw health of poultry
WO2016060934A1 (en) * 2014-10-08 2016-04-21 Novozymes A/S Bacillus strains with fast germination and antimicrobial activity against clostridium perfringens
BR112017015623B1 (pt) 2015-01-23 2022-05-31 Novozymes A/S Ração animal ou aditivo de ração animal ou pré-mistura de ração, método para melhora de um ou mais parâmetros de desempenho de um animal e para alimentação de um animal, e, uso de uma cepa de bacillus
ES2759300T3 (es) 2015-01-23 2020-05-08 Novozymes As Subespecies de Bacillus subtilis
CN107567493B (zh) 2015-01-23 2021-11-16 诺维信公司 改进生产动物的健康和性能的芽孢杆菌属菌株
US10201574B1 (en) 2015-09-16 2019-02-12 Church & Dwight Co., Inc. Methods of microbial treatment of poultry
US11298383B2 (en) 2016-05-20 2022-04-12 Church & Dwight Co., Inc. Lactobacillus and bacillus based direct fed microbial treatment for poultry and method of use
EP3464648A1 (en) 2016-05-25 2019-04-10 Church & Dwight Co., Inc. Bacillus compositions and methods of use with ruminants
EP3464557A1 (en) 2016-05-31 2019-04-10 Evonik Degussa GmbH Bacillus licheniformis
US11173184B2 (en) 2016-05-31 2021-11-16 Evonik Operations Gmbh Bacillus subtilis strain with probiotic activity
EP3645750A1 (en) 2017-06-30 2020-05-06 Evonik Operations GmbH Bacillus pumilus
MX2020000182A (es) 2017-06-30 2020-07-22 Evonik Operations Gmbh Cepa bacillus subtilis con actividad probiotica.
US11622569B2 (en) 2017-07-24 2023-04-11 Church & Dwight Co., Inc. Bacillus microbial terroir for pathogen control in swine
WO2019038153A1 (en) 2017-08-24 2019-02-28 Evonik Degussa Gmbh DEBACILLUS SUBTILIS STRAIN HAVING PROBIOTIC ACTIVITY
EP3447122A1 (en) 2017-08-24 2019-02-27 Evonik Degussa GmbH Bacillus subtilis strain with probiotic activity
CN108865953B (zh) * 2018-07-25 2021-07-13 中国海洋大学 一株广谱抑制水产病原性弧菌的芽孢杆菌及其复合菌制剂
EP3908651A1 (en) 2019-01-10 2021-11-17 Evonik Operations GmbH Fermentation broths and their use
MX2021009443A (es) 2019-02-11 2021-09-10 Evonik Operations Gmbh Composiciones que contienen bacterias productoras de bacillaeno o preparaciones de las mismas.
CN110894132A (zh) * 2019-12-17 2020-03-20 海天水务集团股份公司 一种基于fcr的污水处理方法
EP4090774A1 (en) 2020-01-14 2022-11-23 Evonik Operations GmbH Bacillus strains with the ability to degrade inorganic nitrogen compounds
WO2021146582A1 (en) * 2020-01-17 2021-07-22 AgBiome, Inc. Compositions and methods for controlling undesirable microbes and improving animal health
US20210283199A1 (en) * 2020-03-13 2021-09-16 Kemin Industries, Inc. Method for controlling clostridium infection in animals
MX2023006676A (es) 2020-12-09 2023-07-04 Purina Animal Nutrition Llc Composiciones alimenticias y metodos para inhibir dermatitis ulcerosa focal.
EP4130258A1 (en) 2021-08-02 2023-02-08 Evonik Operations GmbH Microorganisms displaying viral decoy receptors
EP4166002A1 (en) 2021-10-12 2023-04-19 Evonik Operations GmbH Microbial preparations containing specific cryoprotectants
EP4230722A1 (en) 2022-02-17 2023-08-23 Evonik Operations GmbH Bacillota strains with improved outgrowth
EP4230721A1 (en) 2022-02-17 2023-08-23 Evonik Operations GmbH Microorganisms with reduced competence
WO2023180282A1 (en) 2022-03-24 2023-09-28 Evonik Operations Gmbh Co-precipitates of methionylmethionine with organic compounds
WO2023220279A1 (en) * 2022-05-12 2023-11-16 Can Technologies, Inc. Compositions and methods for the treatment and prevention of campylobacter infection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545991A (en) * 1983-06-13 1985-10-08 Merck & Co., Inc. Difficidin and derivative antibacterials
ES2051712T3 (es) * 1986-06-30 1994-07-01 American Cyanamid Co Procedimiento para producir las composiciones denominadas ll-e19020 alfa y ll-e19020 beta.
US4968493A (en) * 1986-06-30 1990-11-06 American Cyanamid Company Method for controlling chronic respiratory disease, fowl cholera and necrotic enteritis in avian species
US5352586A (en) * 1987-05-01 1994-10-04 Biogaia Ab Method of determining the presence of an antibiotic produced by Lactobacillus reuteri
JPH0818996B2 (ja) * 1987-10-31 1996-02-28 カルピス食品工業株式会社 抗クロストリジウム生菌剤
DE69114574T2 (de) * 1990-06-22 1996-05-09 Eniricerche Spa Bazillus subtilis Mutant und Verfahren zur Herstellung von Surfactin durch Verwendung dieses Mutants.
US5364788A (en) * 1991-07-01 1994-11-15 Ahc Inc. Pure culture of Bacillus subtilis FERM BP-3418
ZA926834B (en) * 1991-09-09 1993-03-15 American Cyanamid Co Antibiotic LL-E19020 Gamma.
EP0531640B1 (en) * 1991-09-09 1997-11-26 F. Hoffmann-La Roche Ag Antibiotic LL-E19020 Gamma
JP2528055B2 (ja) * 1991-10-04 1996-08-28 カルピス食品工業株式会社 鳥類飼料添加用腸内サルモネラ属細菌減少剤及びその使用法
WO1999028441A1 (en) 1997-12-01 1999-06-10 Eisai Co., Ltd. Novel bacillus subtilis with antibacterial effects
UA78486C2 (uk) * 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)

Also Published As

Publication number Publication date
ES2331993T3 (es) 2010-01-22
JP4989851B2 (ja) 2012-08-01
EP1576120B1 (en) 2009-08-19
ATE440132T1 (de) 2009-09-15
WO2004050832A2 (en) 2004-06-17
WO2004050832A3 (en) 2005-09-15
AU2003291514A1 (en) 2004-06-23
JP2006514019A (ja) 2006-04-27
US20040101525A1 (en) 2004-05-27
CA2503130C (en) 2012-03-13
US7247299B2 (en) 2007-07-24
AU2003291514B2 (en) 2008-10-09
DE60328916D1 (de) 2009-10-01
EP1576120A4 (en) 2006-06-07
CA2503130A1 (en) 2004-06-17
EP1576120A2 (en) 2005-09-21

Similar Documents

Publication Publication Date Title
US7247299B2 (en) Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
US5951977A (en) Competitive exclusion culture for swine
AU693146B2 (en) Probiotic for control of (salmonella)
De Angelis et al. Selection of potential probiotic lactobacilli from pig feces to be used as additives in pelleted feeding
ES2695149T3 (es) Cepas de Bacillus sensibles a antibióticos que tienen efecto antimicrobiano contra E. coli y Clostridium perfringens y que tienen alta capacidad de esporulación
US7192581B2 (en) Lactobacillus reuteri useful as probiotics
US7754469B2 (en) Microorganisms and methods for treating poultry
US9005601B2 (en) Methods and compositions including spore-forming bacteria for increasing the health of animals
KR20130059950A (ko) 신규한 락토바실러스 속 균주 및 이의 생균제 용도
KR20090040026A (ko) 병원성 세균의 생육을 억제하는 김치에서 분리한 신규류코노스톡 메센트로이드 및 이의 용도
Cho et al. Characterization of Lactobacillus spp. isolated from the feces of breast-feeding piglets
KR20030064462A (ko) 유해세균의 성장을 억제하는 신규 미생물 및 이를유효성분으로 하는 미생물 첨가제
WO2007142597A1 (en) Method and use of lactic acid bacteria with increased acid tolerance
KR101799837B1 (ko) 신규한 엔테로코커스 페칼리스 균주 및 이를 포함하는 프로바이오틱스
KR100445292B1 (ko) 다기능 프로바이오틱능력을 가지는 신규 엔테로코카스 페시움 유비티-엠01
KR20100076263A (ko) 송아지설사병 예방을 위한 신규한 미생물 및 그 용도
JP2007117004A (ja) 胆汁酸耐性細菌を含有する動物用飼料添加剤
Nisbet et al. Competitive exclusion culture for swine

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 12 NOV 2016 BY COMPUTER PACKAGES INC

Effective date: 20131126

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 NOV 2017 BY COMPUTER PACKAGES INC

Effective date: 20161018

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 NOV 2018 BY COMPUTER PACKAGES INC

Effective date: 20171018

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 NOV 2019 BY JAMES + WELLS

Effective date: 20181031

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 NOV 2020 BY IPAN GMBH

Effective date: 20191029

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 NOV 2021 BY IPAN GMBH

Effective date: 20201030

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 NOV 2022 BY IPAN GMBH

Effective date: 20211030

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 12 NOV 2023 BY IPAN GMBH

Effective date: 20221031

EXPY Patent expired